Daniel I. Sullivan

Daniel Sullivan practices at Allegheny General Hospital in Pittsburgh, Pennsylvania, part of Highmark Health.

Daniel Sullivan's NPI, 1013327576, was assigned on May 5, 2014. Daniel Sullivan graduated from University of Alabama School of Medicine in 2014. Daniel Sullivan holds Pennsylvania license MD465152.

Daniel Sullivan's primary practice is Allegheny General Hospital, at 320 East North Avenue, Pittsburgh, PA 15212 in Allegheny County. The practice phone is (412) 359-3131.

Daniel Sullivan's primary practice is Allegheny General Hospital in Pittsburgh, Pennsylvania, part of Highmark Health. Daniel Sullivan is also affiliated with UPMC Presbyterian. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Daniel Sullivan to 1 more hospital, 2 group practices and clinics, 1 breast imaging center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Daniel Sullivan practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Daniel Sullivan's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Daniel Sullivan is licensed in Pennsylvania.

CMS data shows 27 Medicare services from Daniel Sullivan across 1 procedure code in 2024, for 52 Medicare patients. Medicare paid $1,609 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 52 Medicare patients who saw Daniel Sullivan in 2024. The largest group is 65 to 74, with 26 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 29% are also on Medicaid. Their average risk score is 2.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Daniel Sullivan's median patient age at 76, with 65% women.

In 2024, Daniel Sullivan wrote 143 Medicare Part D claims for 19 patients. 72% of them were for generic drugs. CMS names the drug for 65 of them, across 4 drugs with 11 or more claims each, at $4,974 in total drug cost. In 2023, CMS named 140 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Daniel Sullivan for performance year 2024, reported as part of a group. Daniel Sullivan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 4 general payments to Daniel Sullivan from 3 drug and device companies from 2018 to 2023. Speaker and faculty fees make up the largest share, 79% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $795.

Daniel Sullivan graduated from University of Alabama School of Medicine in 2014.